600666.SS · 奥瑞德
China A-shares · RS rating 22 · As of 2026-10-14
| Price | 3.10 CNY |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 22 / 27 / 29 / 51 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 17 / 22 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +51.3% |
| Distance from 52-week high | +56.7% |
| Market cap (USD) | $1.3B |